Among the various NPs under investigation, protein-based NPs such as human serum albumin (HSA) NPs [89] and lactalbumin NPs [91] are emerging as promising bio-inspired nanocarriers due to their natural biocompatibility, non-immunogenicity, high drug loading ability, and tumor-targeting ability. This evidence concerns the gene ALB and neoplasm.